nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Folic Acid Metabolism Inhibitors—Methotrexate—psoriatic arthritis	0.401	1	CiPCiCtD
Pemetrexed—Methotrexate—psoriatic arthritis	0.262	1	CrCtD
Pemetrexed—ATIC—Methotrexate—psoriatic arthritis	0.0522	0.376	CbGbCtD
Pemetrexed—SLC46A1—Methotrexate—psoriatic arthritis	0.0414	0.299	CbGbCtD
Pemetrexed—Leucovorin—Methotrexate—psoriatic arthritis	0.0346	0.2	CrCrCtD
Pemetrexed—Pralatrexate—Methotrexate—psoriatic arthritis	0.0346	0.2	CrCrCtD
Pemetrexed—Raltitrexed—Methotrexate—psoriatic arthritis	0.0346	0.2	CrCrCtD
Pemetrexed—Tetrahydrofolic acid—Methotrexate—psoriatic arthritis	0.0346	0.2	CrCrCtD
Pemetrexed—Folic Acid—Methotrexate—psoriatic arthritis	0.0346	0.2	CrCrCtD
Pemetrexed—DHFR—Methotrexate—psoriatic arthritis	0.0265	0.191	CbGbCtD
Pemetrexed—TYMS—Methotrexate—psoriatic arthritis	0.0185	0.133	CbGbCtD
Pemetrexed—ATIC—pes—psoriatic arthritis	0.00436	0.638	CbGeAlD
Pemetrexed—GART—tendon—psoriatic arthritis	0.000492	0.072	CbGeAlD
Pemetrexed—ATIC—skin of body—psoriatic arthritis	0.000439	0.0642	CbGeAlD
Pemetrexed—SLC46A1—tendon—psoriatic arthritis	0.000399	0.0584	CbGeAlD
Pemetrexed—TYMS—skin of body—psoriatic arthritis	0.000298	0.0435	CbGeAlD
Pemetrexed—TYMS—tendon—psoriatic arthritis	0.000227	0.0331	CbGeAlD
Pemetrexed—DHFR—tendon—psoriatic arthritis	0.000224	0.0328	CbGeAlD
Pemetrexed—SLC29A1—tendon—psoriatic arthritis	0.000203	0.0297	CbGeAlD
Pemetrexed—DCK—tendon—psoriatic arthritis	0.000194	0.0284	CbGeAlD
Pemetrexed—Myocardial infarction—Methylprednisolone—psoriatic arthritis	5.43e-05	0.00303	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	5.43e-05	0.00303	CcSEcCtD
Pemetrexed—Conjunctivitis—Triamcinolone—psoriatic arthritis	5.4e-05	0.00301	CcSEcCtD
Pemetrexed—Mood swings—Prednisone—psoriatic arthritis	5.4e-05	0.00301	CcSEcCtD
Pemetrexed—Renal failure acute—Methotrexate—psoriatic arthritis	5.16e-05	0.00287	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	5.02e-05	0.0028	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Betamethasone—psoriatic arthritis	4.97e-05	0.00277	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	4.97e-05	0.00277	CcSEcCtD
Pemetrexed—Pharyngitis—Triamcinolone—psoriatic arthritis	4.95e-05	0.00276	CcSEcCtD
Pemetrexed—Myocardial infarction—Betamethasone—psoriatic arthritis	4.94e-05	0.00275	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	4.94e-05	0.00275	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Betamethasone—psoriatic arthritis	4.94e-05	0.00275	CcSEcCtD
Pemetrexed—Myocardial infarction—Dexamethasone—psoriatic arthritis	4.94e-05	0.00275	CcSEcCtD
Pemetrexed—Conjunctivitis—Betamethasone—psoriatic arthritis	4.9e-05	0.00273	CcSEcCtD
Pemetrexed—Conjunctivitis—Dexamethasone—psoriatic arthritis	4.9e-05	0.00273	CcSEcCtD
Pemetrexed—Cerebrovascular accident—Methotrexate—psoriatic arthritis	4.86e-05	0.00271	CcSEcCtD
Pemetrexed—Arrhythmia—Prednisolone—psoriatic arthritis	4.84e-05	0.0027	CcSEcCtD
Pemetrexed—Pancreatitis—Prednisone—psoriatic arthritis	4.83e-05	0.00269	CcSEcCtD
Pemetrexed—Erythema—Prednisolone—psoriatic arthritis	4.72e-05	0.00263	CcSEcCtD
Pemetrexed—Eye disorder—Methylprednisolone—psoriatic arthritis	4.65e-05	0.00259	CcSEcCtD
Pemetrexed—Neutropenia—Prednisone—psoriatic arthritis	4.6e-05	0.00256	CcSEcCtD
Pemetrexed—Mood swings—Methotrexate—psoriatic arthritis	4.51e-05	0.00251	CcSEcCtD
Pemetrexed—Arrhythmia—Triamcinolone—psoriatic arthritis	4.45e-05	0.00248	CcSEcCtD
Pemetrexed—Arrhythmia—Methylprednisolone—psoriatic arthritis	4.44e-05	0.00248	CcSEcCtD
Pemetrexed—Erythema—Triamcinolone—psoriatic arthritis	4.34e-05	0.00242	CcSEcCtD
Pemetrexed—Erythema—Methylprednisolone—psoriatic arthritis	4.33e-05	0.00241	CcSEcCtD
Pemetrexed—Malnutrition—Methylprednisolone—psoriatic arthritis	4.33e-05	0.00241	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Prednisone—psoriatic arthritis	4.33e-05	0.00241	CcSEcCtD
Pemetrexed—Myocardial infarction—Prednisone—psoriatic arthritis	4.3e-05	0.0024	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Prednisone—psoriatic arthritis	4.3e-05	0.0024	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	4.29e-05	0.00239	CcSEcCtD
Pemetrexed—Dysgeusia—Triamcinolone—psoriatic arthritis	4.25e-05	0.00237	CcSEcCtD
Pemetrexed—Syncope—Prednisolone—psoriatic arthritis	4.23e-05	0.00236	CcSEcCtD
Pemetrexed—Eye disorder—Betamethasone—psoriatic arthritis	4.23e-05	0.00236	CcSEcCtD
Pemetrexed—Eye disorder—Dexamethasone—psoriatic arthritis	4.23e-05	0.00236	CcSEcCtD
Pemetrexed—Loss of consciousness—Prednisolone—psoriatic arthritis	4.15e-05	0.00231	CcSEcCtD
Pemetrexed—Hypertension—Prednisolone—psoriatic arthritis	4.08e-05	0.00227	CcSEcCtD
Pemetrexed—Arrhythmia—Dexamethasone—psoriatic arthritis	4.04e-05	0.00225	CcSEcCtD
Pemetrexed—Arrhythmia—Betamethasone—psoriatic arthritis	4.04e-05	0.00225	CcSEcCtD
Pemetrexed—Pancreatitis—Methotrexate—psoriatic arthritis	4.03e-05	0.00225	CcSEcCtD
Pemetrexed—Alopecia—Betamethasone—psoriatic arthritis	4e-05	0.00223	CcSEcCtD
Pemetrexed—Alopecia—Dexamethasone—psoriatic arthritis	4e-05	0.00223	CcSEcCtD
Pemetrexed—Erythema—Betamethasone—psoriatic arthritis	3.94e-05	0.00219	CcSEcCtD
Pemetrexed—Erythema—Dexamethasone—psoriatic arthritis	3.94e-05	0.00219	CcSEcCtD
Pemetrexed—Pancytopenia—Methotrexate—psoriatic arthritis	3.91e-05	0.00218	CcSEcCtD
Pemetrexed—Syncope—Triamcinolone—psoriatic arthritis	3.89e-05	0.00217	CcSEcCtD
Pemetrexed—Syncope—Methylprednisolone—psoriatic arthritis	3.88e-05	0.00216	CcSEcCtD
Pemetrexed—Oedema—Prednisolone—psoriatic arthritis	3.85e-05	0.00215	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisolone—psoriatic arthritis	3.85e-05	0.00215	CcSEcCtD
Pemetrexed—Neutropenia—Methotrexate—psoriatic arthritis	3.85e-05	0.00214	CcSEcCtD
Pemetrexed—Loss of consciousness—Triamcinolone—psoriatic arthritis	3.82e-05	0.00213	CcSEcCtD
Pemetrexed—Loss of consciousness—Methylprednisolone—psoriatic arthritis	3.81e-05	0.00212	CcSEcCtD
Pemetrexed—Shock—Prednisolone—psoriatic arthritis	3.79e-05	0.00211	CcSEcCtD
Pemetrexed—Hypertension—Triamcinolone—psoriatic arthritis	3.75e-05	0.00209	CcSEcCtD
Pemetrexed—Hypertension—Methylprednisolone—psoriatic arthritis	3.74e-05	0.00208	CcSEcCtD
Pemetrexed—Myalgia—Triamcinolone—psoriatic arthritis	3.7e-05	0.00206	CcSEcCtD
Pemetrexed—Arthralgia—Methylprednisolone—psoriatic arthritis	3.69e-05	0.00205	CcSEcCtD
Pemetrexed—Myalgia—Methylprednisolone—psoriatic arthritis	3.69e-05	0.00205	CcSEcCtD
Pemetrexed—Eye disorder—Prednisone—psoriatic arthritis	3.68e-05	0.00205	CcSEcCtD
Pemetrexed—Infestation—Methotrexate—psoriatic arthritis	3.67e-05	0.00204	CcSEcCtD
Pemetrexed—Infestation NOS—Methotrexate—psoriatic arthritis	3.67e-05	0.00204	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	3.66e-05	0.00204	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	3.64e-05	0.00203	CcSEcCtD
Pemetrexed—Renal failure—Methotrexate—psoriatic arthritis	3.61e-05	0.00201	CcSEcCtD
Pemetrexed—Stomatitis—Methotrexate—psoriatic arthritis	3.58e-05	0.00199	CcSEcCtD
Pemetrexed—Conjunctivitis—Methotrexate—psoriatic arthritis	3.57e-05	0.00199	CcSEcCtD
Pemetrexed—Oedema—Triamcinolone—psoriatic arthritis	3.54e-05	0.00197	CcSEcCtD
Pemetrexed—Anaphylactic shock—Triamcinolone—psoriatic arthritis	3.54e-05	0.00197	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	3.53e-05	0.00197	CcSEcCtD
Pemetrexed—Syncope—Betamethasone—psoriatic arthritis	3.53e-05	0.00197	CcSEcCtD
Pemetrexed—Syncope—Dexamethasone—psoriatic arthritis	3.53e-05	0.00197	CcSEcCtD
Pemetrexed—Arrhythmia—Prednisone—psoriatic arthritis	3.52e-05	0.00196	CcSEcCtD
Pemetrexed—Infection—Triamcinolone—psoriatic arthritis	3.52e-05	0.00196	CcSEcCtD
Pemetrexed—Infection—Methylprednisolone—psoriatic arthritis	3.51e-05	0.00196	CcSEcCtD
Pemetrexed—Shock—Triamcinolone—psoriatic arthritis	3.49e-05	0.00194	CcSEcCtD
Pemetrexed—Alopecia—Prednisone—psoriatic arthritis	3.48e-05	0.00194	CcSEcCtD
Pemetrexed—Shock—Methylprednisolone—psoriatic arthritis	3.48e-05	0.00194	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Methotrexate—psoriatic arthritis	3.47e-05	0.00193	CcSEcCtD
Pemetrexed—Nervous system disorder—Methylprednisolone—psoriatic arthritis	3.47e-05	0.00193	CcSEcCtD
Pemetrexed—Loss of consciousness—Betamethasone—psoriatic arthritis	3.46e-05	0.00193	CcSEcCtD
Pemetrexed—Loss of consciousness—Dexamethasone—psoriatic arthritis	3.46e-05	0.00193	CcSEcCtD
Pemetrexed—Skin disorder—Methylprednisolone—psoriatic arthritis	3.43e-05	0.00191	CcSEcCtD
Pemetrexed—Erythema—Prednisone—psoriatic arthritis	3.43e-05	0.00191	CcSEcCtD
Pemetrexed—Malnutrition—Prednisone—psoriatic arthritis	3.43e-05	0.00191	CcSEcCtD
Pemetrexed—Agranulocytosis—Methotrexate—psoriatic arthritis	3.42e-05	0.00191	CcSEcCtD
Pemetrexed—Hypertension—Betamethasone—psoriatic arthritis	3.4e-05	0.00189	CcSEcCtD
Pemetrexed—Hypertension—Dexamethasone—psoriatic arthritis	3.4e-05	0.00189	CcSEcCtD
Pemetrexed—Myalgia—Betamethasone—psoriatic arthritis	3.35e-05	0.00187	CcSEcCtD
Pemetrexed—Myalgia—Dexamethasone—psoriatic arthritis	3.35e-05	0.00187	CcSEcCtD
Pemetrexed—Pain—Prednisolone—psoriatic arthritis	3.29e-05	0.00183	CcSEcCtD
Pemetrexed—Hepatitis—Methotrexate—psoriatic arthritis	3.29e-05	0.00183	CcSEcCtD
Pemetrexed—Pharyngitis—Methotrexate—psoriatic arthritis	3.27e-05	0.00182	CcSEcCtD
Pemetrexed—Urinary tract disorder—Methotrexate—psoriatic arthritis	3.25e-05	0.00181	CcSEcCtD
Pemetrexed—Urethral disorder—Methotrexate—psoriatic arthritis	3.23e-05	0.0018	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	3.23e-05	0.0018	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	3.22e-05	0.00179	CcSEcCtD
Pemetrexed—Oedema—Dexamethasone—psoriatic arthritis	3.21e-05	0.00179	CcSEcCtD
Pemetrexed—Oedema—Betamethasone—psoriatic arthritis	3.21e-05	0.00179	CcSEcCtD
Pemetrexed—Anaphylactic shock—Betamethasone—psoriatic arthritis	3.21e-05	0.00179	CcSEcCtD
Pemetrexed—Anaphylactic shock—Dexamethasone—psoriatic arthritis	3.21e-05	0.00179	CcSEcCtD
Pemetrexed—Infection—Betamethasone—psoriatic arthritis	3.19e-05	0.00178	CcSEcCtD
Pemetrexed—Infection—Dexamethasone—psoriatic arthritis	3.19e-05	0.00178	CcSEcCtD
Pemetrexed—Anaemia—Prednisone—psoriatic arthritis	3.17e-05	0.00177	CcSEcCtD
Pemetrexed—Shock—Dexamethasone—psoriatic arthritis	3.16e-05	0.00176	CcSEcCtD
Pemetrexed—Shock—Betamethasone—psoriatic arthritis	3.16e-05	0.00176	CcSEcCtD
Pemetrexed—Dyspnoea—Triamcinolone—psoriatic arthritis	3.16e-05	0.00176	CcSEcCtD
Pemetrexed—Nervous system disorder—Dexamethasone—psoriatic arthritis	3.15e-05	0.00176	CcSEcCtD
Pemetrexed—Nervous system disorder—Betamethasone—psoriatic arthritis	3.15e-05	0.00176	CcSEcCtD
Pemetrexed—Thrombocytopenia—Dexamethasone—psoriatic arthritis	3.15e-05	0.00175	CcSEcCtD
Pemetrexed—Thrombocytopenia—Betamethasone—psoriatic arthritis	3.15e-05	0.00175	CcSEcCtD
Pemetrexed—Dyspepsia—Triamcinolone—psoriatic arthritis	3.12e-05	0.00174	CcSEcCtD
Pemetrexed—Erythema multiforme—Methotrexate—psoriatic arthritis	3.11e-05	0.00173	CcSEcCtD
Pemetrexed—Dyspepsia—Methylprednisolone—psoriatic arthritis	3.11e-05	0.00173	CcSEcCtD
Pemetrexed—Eye disorder—Methotrexate—psoriatic arthritis	3.08e-05	0.00171	CcSEcCtD
Pemetrexed—Syncope—Prednisone—psoriatic arthritis	3.08e-05	0.00171	CcSEcCtD
Pemetrexed—Anorexia—Dexamethasone—psoriatic arthritis	3.06e-05	0.00171	CcSEcCtD
Pemetrexed—Anorexia—Betamethasone—psoriatic arthritis	3.06e-05	0.00171	CcSEcCtD
Pemetrexed—Urticaria—Prednisolone—psoriatic arthritis	3.06e-05	0.0017	CcSEcCtD
Pemetrexed—Fatigue—Triamcinolone—psoriatic arthritis	3.05e-05	0.0017	CcSEcCtD
Pemetrexed—Fatigue—Methylprednisolone—psoriatic arthritis	3.05e-05	0.0017	CcSEcCtD
Pemetrexed—Pain—Triamcinolone—psoriatic arthritis	3.03e-05	0.00169	CcSEcCtD
Pemetrexed—Loss of consciousness—Prednisone—psoriatic arthritis	3.01e-05	0.00168	CcSEcCtD
Pemetrexed—Hypertension—Prednisone—psoriatic arthritis	2.96e-05	0.00165	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	2.93e-05	0.00163	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	2.93e-05	0.00163	CcSEcCtD
Pemetrexed—Myalgia—Prednisone—psoriatic arthritis	2.92e-05	0.00163	CcSEcCtD
Pemetrexed—Arthralgia—Prednisone—psoriatic arthritis	2.92e-05	0.00163	CcSEcCtD
Pemetrexed—Alopecia—Methotrexate—psoriatic arthritis	2.91e-05	0.00162	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	2.9e-05	0.00162	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	2.89e-05	0.00161	CcSEcCtD
Pemetrexed—Erythema—Methotrexate—psoriatic arthritis	2.87e-05	0.0016	CcSEcCtD
Pemetrexed—Malnutrition—Methotrexate—psoriatic arthritis	2.87e-05	0.0016	CcSEcCtD
Pemetrexed—Hypersensitivity—Prednisolone—psoriatic arthritis	2.84e-05	0.00158	CcSEcCtD
Pemetrexed—Dyspepsia—Dexamethasone—psoriatic arthritis	2.83e-05	0.00158	CcSEcCtD
Pemetrexed—Dyspepsia—Betamethasone—psoriatic arthritis	2.83e-05	0.00158	CcSEcCtD
Pemetrexed—Urticaria—Triamcinolone—psoriatic arthritis	2.81e-05	0.00157	CcSEcCtD
Pemetrexed—Urticaria—Methylprednisolone—psoriatic arthritis	2.81e-05	0.00156	CcSEcCtD
Pemetrexed—Dysgeusia—Methotrexate—psoriatic arthritis	2.81e-05	0.00156	CcSEcCtD
Pemetrexed—Body temperature increased—Triamcinolone—psoriatic arthritis	2.8e-05	0.00156	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisone—psoriatic arthritis	2.8e-05	0.00156	CcSEcCtD
Pemetrexed—Oedema—Prednisone—psoriatic arthritis	2.8e-05	0.00156	CcSEcCtD
Pemetrexed—Abdominal pain—Methylprednisolone—psoriatic arthritis	2.79e-05	0.00156	CcSEcCtD
Pemetrexed—Decreased appetite—Betamethasone—psoriatic arthritis	2.79e-05	0.00156	CcSEcCtD
Pemetrexed—Decreased appetite—Dexamethasone—psoriatic arthritis	2.79e-05	0.00156	CcSEcCtD
Pemetrexed—Infection—Prednisone—psoriatic arthritis	2.78e-05	0.00155	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	2.78e-05	0.00155	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	2.78e-05	0.00155	CcSEcCtD
Pemetrexed—Fatigue—Dexamethasone—psoriatic arthritis	2.77e-05	0.00154	CcSEcCtD
Pemetrexed—Fatigue—Betamethasone—psoriatic arthritis	2.77e-05	0.00154	CcSEcCtD
Pemetrexed—Shock—Prednisone—psoriatic arthritis	2.75e-05	0.00153	CcSEcCtD
Pemetrexed—Pain—Betamethasone—psoriatic arthritis	2.75e-05	0.00153	CcSEcCtD
Pemetrexed—Pain—Dexamethasone—psoriatic arthritis	2.75e-05	0.00153	CcSEcCtD
Pemetrexed—Nervous system disorder—Prednisone—psoriatic arthritis	2.75e-05	0.00153	CcSEcCtD
Pemetrexed—Skin disorder—Prednisone—psoriatic arthritis	2.72e-05	0.00151	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Methylprednisolone—psoriatic arthritis	2.68e-05	0.0279	CbGdCrCtD
Pemetrexed—Anorexia—Prednisone—psoriatic arthritis	2.67e-05	0.00149	CcSEcCtD
Pemetrexed—Anaemia—Methotrexate—psoriatic arthritis	2.65e-05	0.00148	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Dexamethasone—psoriatic arthritis	2.63e-05	0.0275	CbGdCrCtD
Pemetrexed—DCK—Desoximetasone—Betamethasone—psoriatic arthritis	2.63e-05	0.0275	CbGdCrCtD
Pemetrexed—Gastrointestinal pain—Betamethasone—psoriatic arthritis	2.63e-05	0.00146	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	2.63e-05	0.00146	CcSEcCtD
Pemetrexed—Hypersensitivity—Triamcinolone—psoriatic arthritis	2.61e-05	0.00145	CcSEcCtD
Pemetrexed—Hypersensitivity—Methylprednisolone—psoriatic arthritis	2.6e-05	0.00145	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Methylprednisolone—psoriatic arthritis	2.6e-05	0.0271	CbGdCrCtD
Pemetrexed—DCK—Desoximetasone—Triamcinolone—psoriatic arthritis	2.57e-05	0.0269	CbGdCrCtD
Pemetrexed—Leukopenia—Methotrexate—psoriatic arthritis	2.57e-05	0.00143	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Betamethasone—psoriatic arthritis	2.56e-05	0.0267	CbGdCrCtD
Pemetrexed—DCK—Diflorasone—Dexamethasone—psoriatic arthritis	2.56e-05	0.0267	CbGdCrCtD
Pemetrexed—Urticaria—Dexamethasone—psoriatic arthritis	2.55e-05	0.00142	CcSEcCtD
Pemetrexed—Urticaria—Betamethasone—psoriatic arthritis	2.55e-05	0.00142	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	2.55e-05	0.00142	CcSEcCtD
Pemetrexed—Dizziness—Prednisolone—psoriatic arthritis	2.55e-05	0.00142	CcSEcCtD
Pemetrexed—Asthenia—Triamcinolone—psoriatic arthritis	2.54e-05	0.00142	CcSEcCtD
Pemetrexed—Abdominal pain—Dexamethasone—psoriatic arthritis	2.54e-05	0.00142	CcSEcCtD
Pemetrexed—Abdominal pain—Betamethasone—psoriatic arthritis	2.54e-05	0.00142	CcSEcCtD
Pemetrexed—Body temperature increased—Dexamethasone—psoriatic arthritis	2.54e-05	0.00142	CcSEcCtD
Pemetrexed—Body temperature increased—Betamethasone—psoriatic arthritis	2.54e-05	0.00142	CcSEcCtD
Pemetrexed—Asthenia—Methylprednisolone—psoriatic arthritis	2.54e-05	0.00141	CcSEcCtD
Pemetrexed—Pruritus—Triamcinolone—psoriatic arthritis	2.51e-05	0.0014	CcSEcCtD
Pemetrexed—Pruritus—Methylprednisolone—psoriatic arthritis	2.5e-05	0.00139	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Triamcinolone—psoriatic arthritis	2.5e-05	0.0261	CbGdCrCtD
Pemetrexed—Dyspepsia—Prednisone—psoriatic arthritis	2.46e-05	0.00137	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Prednisone—psoriatic arthritis	2.44e-05	0.0255	CbGdCrCtD
Pemetrexed—Arthralgia—Methotrexate—psoriatic arthritis	2.44e-05	0.00136	CcSEcCtD
Pemetrexed—Chest pain—Methotrexate—psoriatic arthritis	2.44e-05	0.00136	CcSEcCtD
Pemetrexed—Myalgia—Methotrexate—psoriatic arthritis	2.44e-05	0.00136	CcSEcCtD
Pemetrexed—Decreased appetite—Prednisone—psoriatic arthritis	2.43e-05	0.00136	CcSEcCtD
Pemetrexed—Rash—Prednisolone—psoriatic arthritis	2.43e-05	0.00135	CcSEcCtD
Pemetrexed—Dermatitis—Prednisolone—psoriatic arthritis	2.43e-05	0.00135	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	2.42e-05	0.00135	CcSEcCtD
Pemetrexed—Diarrhoea—Methylprednisolone—psoriatic arthritis	2.42e-05	0.00135	CcSEcCtD
Pemetrexed—Fatigue—Prednisone—psoriatic arthritis	2.41e-05	0.00134	CcSEcCtD
Pemetrexed—Constipation—Prednisone—psoriatic arthritis	2.39e-05	0.00133	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Prednisolone—psoriatic arthritis	2.38e-05	0.0249	CbGdCrCtD
Pemetrexed—DCK—Diflorasone—Prednisone—psoriatic arthritis	2.37e-05	0.0248	CbGdCrCtD
Pemetrexed—Dizziness—Triamcinolone—psoriatic arthritis	2.34e-05	0.0013	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methotrexate—psoriatic arthritis	2.34e-05	0.0013	CcSEcCtD
Pemetrexed—Dizziness—Methylprednisolone—psoriatic arthritis	2.34e-05	0.0013	CcSEcCtD
Pemetrexed—Infection—Methotrexate—psoriatic arthritis	2.32e-05	0.00129	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Prednisolone—psoriatic arthritis	2.31e-05	0.0242	CbGdCrCtD
Pemetrexed—Asthenia—Dexamethasone—psoriatic arthritis	2.31e-05	0.00128	CcSEcCtD
Pemetrexed—Asthenia—Betamethasone—psoriatic arthritis	2.31e-05	0.00128	CcSEcCtD
Pemetrexed—Nervous system disorder—Methotrexate—psoriatic arthritis	2.29e-05	0.00128	CcSEcCtD
Pemetrexed—Thrombocytopenia—Methotrexate—psoriatic arthritis	2.29e-05	0.00128	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Prednisone—psoriatic arthritis	2.29e-05	0.00128	CcSEcCtD
Pemetrexed—Nausea—Prednisolone—psoriatic arthritis	2.29e-05	0.00127	CcSEcCtD
Pemetrexed—Pruritus—Betamethasone—psoriatic arthritis	2.27e-05	0.00127	CcSEcCtD
Pemetrexed—Pruritus—Dexamethasone—psoriatic arthritis	2.27e-05	0.00127	CcSEcCtD
Pemetrexed—Skin disorder—Methotrexate—psoriatic arthritis	2.27e-05	0.00127	CcSEcCtD
Pemetrexed—Vomiting—Triamcinolone—psoriatic arthritis	2.25e-05	0.00125	CcSEcCtD
Pemetrexed—Vomiting—Methylprednisolone—psoriatic arthritis	2.25e-05	0.00125	CcSEcCtD
Pemetrexed—Rash—Triamcinolone—psoriatic arthritis	2.23e-05	0.00124	CcSEcCtD
Pemetrexed—Dermatitis—Triamcinolone—psoriatic arthritis	2.23e-05	0.00124	CcSEcCtD
Pemetrexed—Anorexia—Methotrexate—psoriatic arthritis	2.23e-05	0.00124	CcSEcCtD
Pemetrexed—Rash—Methylprednisolone—psoriatic arthritis	2.23e-05	0.00124	CcSEcCtD
Pemetrexed—Dermatitis—Methylprednisolone—psoriatic arthritis	2.23e-05	0.00124	CcSEcCtD
Pemetrexed—Urticaria—Prednisone—psoriatic arthritis	2.22e-05	0.00124	CcSEcCtD
Pemetrexed—Abdominal pain—Prednisone—psoriatic arthritis	2.21e-05	0.00123	CcSEcCtD
Pemetrexed—Body temperature increased—Prednisone—psoriatic arthritis	2.21e-05	0.00123	CcSEcCtD
Pemetrexed—Diarrhoea—Betamethasone—psoriatic arthritis	2.2e-05	0.00123	CcSEcCtD
Pemetrexed—Diarrhoea—Dexamethasone—psoriatic arthritis	2.2e-05	0.00123	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Methylprednisolone—psoriatic arthritis	2.17e-05	0.0227	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Methylprednisolone—psoriatic arthritis	2.14e-05	0.0224	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Betamethasone—psoriatic arthritis	2.14e-05	0.0223	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Dexamethasone—psoriatic arthritis	2.14e-05	0.0223	CbGdCrCtD
Pemetrexed—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	2.13e-05	0.00119	CcSEcCtD
Pemetrexed—Dizziness—Betamethasone—psoriatic arthritis	2.13e-05	0.00118	CcSEcCtD
Pemetrexed—Dizziness—Dexamethasone—psoriatic arthritis	2.13e-05	0.00118	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Methylprednisolone—psoriatic arthritis	2.12e-05	0.0222	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Betamethasone—psoriatic arthritis	2.11e-05	0.022	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Dexamethasone—psoriatic arthritis	2.11e-05	0.022	CbGdCrCtD
Pemetrexed—Nausea—Triamcinolone—psoriatic arthritis	2.1e-05	0.00117	CcSEcCtD
Pemetrexed—Nausea—Methylprednisolone—psoriatic arthritis	2.1e-05	0.00117	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Triamcinolone—psoriatic arthritis	2.09e-05	0.0218	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Dexamethasone—psoriatic arthritis	2.09e-05	0.0218	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Betamethasone—psoriatic arthritis	2.09e-05	0.0218	CbGdCrCtD
Pemetrexed—Dyspnoea—Methotrexate—psoriatic arthritis	2.09e-05	0.00116	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	2.07e-05	0.0216	CbGdCrCtD
Pemetrexed—Hypersensitivity—Prednisone—psoriatic arthritis	2.06e-05	0.00115	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Triamcinolone—psoriatic arthritis	2.06e-05	0.0215	CbGdCrCtD
Pemetrexed—Dyspepsia—Methotrexate—psoriatic arthritis	2.06e-05	0.00115	CcSEcCtD
Pemetrexed—Vomiting—Betamethasone—psoriatic arthritis	2.04e-05	0.00114	CcSEcCtD
Pemetrexed—Vomiting—Dexamethasone—psoriatic arthritis	2.04e-05	0.00114	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	2.04e-05	0.0213	CbGdCrCtD
Pemetrexed—TYMS—Fluticasone Propionate—Betamethasone—psoriatic arthritis	2.04e-05	0.0213	CbGdCrCtD
Pemetrexed—Decreased appetite—Methotrexate—psoriatic arthritis	2.03e-05	0.00113	CcSEcCtD
Pemetrexed—Rash—Betamethasone—psoriatic arthritis	2.03e-05	0.00113	CcSEcCtD
Pemetrexed—Rash—Dexamethasone—psoriatic arthritis	2.03e-05	0.00113	CcSEcCtD
Pemetrexed—Dermatitis—Dexamethasone—psoriatic arthritis	2.02e-05	0.00113	CcSEcCtD
Pemetrexed—Dermatitis—Betamethasone—psoriatic arthritis	2.02e-05	0.00113	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	2.02e-05	0.00113	CcSEcCtD
Pemetrexed—Fatigue—Methotrexate—psoriatic arthritis	2.02e-05	0.00112	CcSEcCtD
Pemetrexed—Asthenia—Prednisone—psoriatic arthritis	2.01e-05	0.00112	CcSEcCtD
Pemetrexed—Pain—Methotrexate—psoriatic arthritis	2e-05	0.00111	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	1.99e-05	0.0208	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisone—psoriatic arthritis	1.98e-05	0.0207	CbGdCrCtD
Pemetrexed—Pruritus—Prednisone—psoriatic arthritis	1.98e-05	0.0011	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Prednisone—psoriatic arthritis	1.96e-05	0.0204	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Methylprednisolone—psoriatic arthritis	1.96e-05	0.0204	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Prednisone—psoriatic arthritis	1.94e-05	0.0202	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisolone—psoriatic arthritis	1.93e-05	0.0202	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Betamethasone—psoriatic arthritis	1.92e-05	0.0201	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Dexamethasone—psoriatic arthritis	1.92e-05	0.0201	CbGdCrCtD
Pemetrexed—Diarrhoea—Prednisone—psoriatic arthritis	1.92e-05	0.00107	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methotrexate—psoriatic arthritis	1.91e-05	0.00107	CcSEcCtD
Pemetrexed—Nausea—Dexamethasone—psoriatic arthritis	1.91e-05	0.00106	CcSEcCtD
Pemetrexed—Nausea—Betamethasone—psoriatic arthritis	1.91e-05	0.00106	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Prednisolone—psoriatic arthritis	1.91e-05	0.0199	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Prednisolone—psoriatic arthritis	1.89e-05	0.0197	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Triamcinolone—psoriatic arthritis	1.88e-05	0.0196	CbGdCrCtD
Pemetrexed—Urticaria—Methotrexate—psoriatic arthritis	1.86e-05	0.00104	CcSEcCtD
Pemetrexed—Dizziness—Prednisone—psoriatic arthritis	1.85e-05	0.00103	CcSEcCtD
Pemetrexed—Body temperature increased—Methotrexate—psoriatic arthritis	1.85e-05	0.00103	CcSEcCtD
Pemetrexed—Abdominal pain—Methotrexate—psoriatic arthritis	1.85e-05	0.00103	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Prednisone—psoriatic arthritis	1.78e-05	0.0186	CbGdCrCtD
Pemetrexed—Vomiting—Prednisone—psoriatic arthritis	1.78e-05	0.000991	CcSEcCtD
Pemetrexed—Rash—Prednisone—psoriatic arthritis	1.77e-05	0.000983	CcSEcCtD
Pemetrexed—Dermatitis—Prednisone—psoriatic arthritis	1.76e-05	0.000982	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Prednisolone—psoriatic arthritis	1.74e-05	0.0182	CbGdCrCtD
Pemetrexed—Hypersensitivity—Methotrexate—psoriatic arthritis	1.72e-05	0.00096	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Methylprednisolone—psoriatic arthritis	1.71e-05	0.0179	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Dexamethasone—psoriatic arthritis	1.69e-05	0.0176	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Betamethasone—psoriatic arthritis	1.69e-05	0.0176	CbGdCrCtD
Pemetrexed—Asthenia—Methotrexate—psoriatic arthritis	1.68e-05	0.000935	CcSEcCtD
Pemetrexed—Nausea—Prednisone—psoriatic arthritis	1.66e-05	0.000926	CcSEcCtD
Pemetrexed—Pruritus—Methotrexate—psoriatic arthritis	1.66e-05	0.000922	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Triamcinolone—psoriatic arthritis	1.65e-05	0.0172	CbGdCrCtD
Pemetrexed—Diarrhoea—Methotrexate—psoriatic arthritis	1.6e-05	0.000892	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Prednisone—psoriatic arthritis	1.56e-05	0.0163	CbGdCrCtD
Pemetrexed—Dizziness—Methotrexate—psoriatic arthritis	1.55e-05	0.000862	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Prednisolone—psoriatic arthritis	1.53e-05	0.0159	CbGdCrCtD
Pemetrexed—TYMS—Danazol—Prednisone—psoriatic arthritis	1.5e-05	0.0157	CbGdCrCtD
Pemetrexed—Vomiting—Methotrexate—psoriatic arthritis	1.49e-05	0.000829	CcSEcCtD
Pemetrexed—Rash—Methotrexate—psoriatic arthritis	1.48e-05	0.000822	CcSEcCtD
Pemetrexed—Dermatitis—Methotrexate—psoriatic arthritis	1.47e-05	0.000821	CcSEcCtD
Pemetrexed—Nausea—Methotrexate—psoriatic arthritis	1.39e-05	0.000774	CcSEcCtD
